Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Faster, Cleaner, Better.

Alseres Pharmaceuticals Inc (ALSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2011	09-2011	06-2011	03-2011	12-2010
Assets
Current Assets
Cash & Cash Equivalents	136	86	74	14	99
Marketable Securities	27	59	N/A	N/A	N/A
Other current assets	0	71	96	96	96
TOTAL	$168	$263	$208	$155	$209

Non-Current Assets
PPE Net	3	3	20	34	48
Other Non-Current Assets	0	115	116	204	204
TOTAL	$3	$118	$136	$238	$252

Total Assets	$171	$381	$344	$393	$461

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	2,210	2,318	2,808	3,549	8,292
Accrued Expenses	N/A	0	0	69	66
TOTAL	$30,425	$44,290	$43,805	$43,312	$42,288

Non-Current Liabilities
Other Non-Current Liabilities	348	343	338	5,528	5,459
TOTAL	$348	$343	$338	$5,528	$5,459

Total Liabilities	$30,773	$44,633	$44,142	$48,840	$47,747

Shareholders' Equity
Shares Outstanding, K	6	6	6	5	5
Common Shares	306	317	314	268	268
Retained earnings	-197,048	-196,253	-195,776	-195,243	-194,166
Other shareholders' equity	-31	0	0	0	0
TOTAL	$-30,602	$-44,252	$-43,798	$-48,447	$-47,286

Total Liabilities And Equity	$171	$381	$344	$393	$461